The transaction accelerates the expiration of biosimilars non-compete restrictions, the company said.

Pfizer is paying top dollar for a GLP-1 candidate from Fosun Pharma. Zealand Pharma penned a platform deal with brand new ...

IISc Bengaluru establishes TANUH, an AI Centre of Excellence, to innovate scalable healthcare solutions for non-communicable ...

Bengaluru: Biocon Biologics Limited, a fully integrated, global biosimilars company and subsidiary of Biocon Ltd. has ...

Viatris ( (VTRS) ) has provided an announcement. On December 6, 2025, Viatris Inc. announced an agreement to sell its equity stake in Biocon Biologics Limited to Biocon Limited for $815 million, ...

USC noted that the award also acknowledges Murthy’s philanthropic engagement in education, research and rural development ...

Kiran Mazumdar-Shaw honoured with ‘USC Business Management Award’ for her contributions in global healthcare and biotechnology: Our Bureau, Bengaluru Wednesday, December 10, 2 ...

Biocon Limited ( ($IN:BIOCON) ) has shared an announcement. Biocon Limited announced that India Ratings and Research has assigned and affirmed ...

Viatris is letting go of the equity stake it’s held in Biocon’s biosimilar subsidiary Biocon Biologics for $815 million, allowing Biocon to fully integrate its subsidiary. | Returning its stake in ...

Brokerages say Biocon's move to fully acquire Biocon Biologics simplifies structure and unlocks value, but near-term stock ...

Full-service law firm Khaitan & Co has appointed Dr. Vimal Choudhary as Chief Operating Officer to lead its internal operations and drive ...

Motilal Oswal is bullish on Biocon recommended buy rating on the stock with a target price of Rs 460 in its research report ...